Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


GSK2983559


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-112038A-5MG 5 mg 144,00 122,40 Add
HY-112038A-10MG 10 mg 228,00 193,80 Add
HY-112038A-25MG 25 mg 418,00 355,30 Add
HY-112038A-50MG 50 mg 775,00 658,80 Add
HY-112038A-100MG 100 mg 1'156,00 982,60 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

GSK2983559 (compound 3) is a potent, specific and oral bioavailable receptor interacting protein 2 (RIP2) kinase inhibitor, which has excellent activity in blocking many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples.

Category Biochemicals
Supplier MedChem Express
Application COVID-19-immunoregulation
Regulatory Status RUO
Format Solubility: DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble) ; DMF : < 1 mg/mL (ult...
Grade Clinical information: No Development Reported
Molecular Formula C21H28CaN4O10PS2
Molecular Weight 611.61
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland